Zai Lab Announces Oral Presentation of Updated Data from Global Phase 1 Trial of Zocilurtatug Pelitecan (ZL-1310), a Potential First-in-Class DLL3-Targeted ADC, at 2025 AACR-NCI-EORTC Conference - ...
LOS ANGELES, Sept. 24, 2025 /PRNewswire/ -- Fuel Cycle, the leader in AI-native research technology, today announced the launch of Presentation Designer, a capability within its Autonomous Insights ...